Pumphrey v. Triad Life Sciences

CourtCourt of Appeals for the Fifth Circuit
DecidedSeptember 6, 2024
Docket24-60028
StatusUnpublished

This text of Pumphrey v. Triad Life Sciences (Pumphrey v. Triad Life Sciences) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Pumphrey v. Triad Life Sciences, (5th Cir. 2024).

Opinion

Case: 24-60028 Document: 81-1 Page: 1 Date Filed: 09/06/2024

United States Court of Appeals for the Fifth Circuit United States Court of Appeals Fifth Circuit ____________ FILED September 6, 2024 No. 24-60028 Lyle W. Cayce ____________ Clerk

Samuel Tony Pumphrey,

Plaintiff—Appellee,

versus

Triad Life Sciences, Incorporated; Convatec Triad Life Sciences, L.L.C.,

Defendants—Appellants. ______________________________

Appeal from the United States District Court for the Northern District of Mississippi USDC No. 3:23-CV-299 ______________________________

Before Jones, Willett, and Engelhardt, Circuit Judges. Per Curiam:* This is an interlocutory appeal from the denial of a motion to compel arbitration. The district court found that Triad Life Sciences waived its right to arbitration by moving to dismiss Samuel Pumphrey’s wrongful- termination claim under Rule 12(b)(6). We disagree and REVERSE.

* This opinion is not designated for publication. See 5th Cir. R. 47.5. Case: 24-60028 Document: 81-1 Page: 2 Date Filed: 09/06/2024

No. 24-60028

I A This case arises from an employment dispute in Oxford, Mississippi. The plaintiff, Samuel Pumphrey, began working for Triad Life Sciences 1 a few years ago as a sales director for wound graft products. According to Pumphrey, he excelled in this role, collecting millions of dollars in revenue and never receiving “a single complaint about his performance.” Pumphrey attributes his success to his “fifteen years of experience in the medical device industry.” Also attributable to his experience, Pumphrey says, is his knowledge of the “federal laws that govern the medical industry,” including the anti- kickback statute, codified at 42 U.S.C. § 1320a-7b. And it was “[b]ecause of his familiarity with the” anti-kickback statute, Pumphrey continues, that he “grew concerned when he learned that” Triad’s CEO, Russel Olsen, had allegedly “enticed physicians to purchase from [Triad] with significant monetary inducements.” Eventually, Pumphrey reported Olsen’s activity to others at Triad. Yet none of them, Pumphrey says, took his concerns seriously. A few days after he reported Olsen’s activity, Pumphrey was notified that his “position was being eliminated pursuant to a corporate restructuring.” As Triad explains, it “was acquired by Convatec, Inc., resulting in various corporate reorganizations to integrate the new Convatec entity . . . into the broader Convatec enterprise.” According to Pumphrey,

1 About a year into Pumphrey’s employment, Triad was acquired by Convatec, Inc., the other named defendant in this lawsuit. For simplicity, we refer to both defendants as “Triad.”

2 Case: 24-60028 Document: 81-1 Page: 3 Date Filed: 09/06/2024

however, Triad’s reason for his termination—corporate restructuring—was “pretextual,” the real reason being his decision to report Olsen’s conduct. B Based on that belief, Pumphrey sued both Triad and Convatec, asserting a single common-law wrongful-termination claim. Pumphrey specifically asserted a so-called “McArn claim,” derived from the eponymous case of McArn v. Allied Bruce-Terminix Co., in which the Mississippi Supreme Court held that “an employee who is discharged for reporting [the] illegal acts of his employer” can sue in tort for damages. 626 So.2d 603, 607 (Miss. 1993). In his original five-page complaint, Pumphrey simply alleged that, “[d]uring the course of his employment, [he] learned that [Triad’s] CEO was offering monetary inducements to physicians to gain their business” and thus violated the anti-kickback statute. Based on that single allegation, Triad moved to dismiss Pumphrey’s claim under Rule 12(b)(6), arguing that he had not pleaded a viable McArn claim and that his complaint failed to meet federal pleadings standards. Nine days later, Pumphrey filed his first amended complaint, adding facts that (he argued) cured any deficiency in his original complaint. Then, a little over a month later, Triad filed three motions on the same day: (1) a motion to compel arbitration, (2) a motion to dismiss for lack of personal jurisdiction, and (3) another motion to dismiss for failure to state a claim. In the motion to compel arbitration, Triad, for the first time in the litigation, pointed to an arbitration clause in Pumphrey’s offer letter: [A]ny controversy, dispute or claim arising out of or relating in any way to this Agreement or to your employment with Triad, . . . including all disputes related to or arising out of your termination of your employment, and including without limitation any and all statutory or common law claims arising

3 Case: 24-60028 Document: 81-1 Page: 4 Date Filed: 09/06/2024

out of or relating in any way to your employment with Triad, shall be mediated in good faith . . . pursuant to the National Employment Arbitration Rules and Mediation Procedures of the American Arbitration Association. No one disputes the validity of the arbitration clause above. Nor does anyone dispute that its terms encompass Pumphrey’s claim against Triad. Instead, Pumphrey argued to the district court, and now maintains on appeal, that Triad waived its right to compel arbitration by moving to dismiss his claim. The district court agreed. “If found persuasive,” the district court reasoned, Triad’s “arguments constitute a clear basis for dismissing this case with prejudice, and this court concludes that, by filing their motion to dismiss, defendants ‘substantially invoked the judicial process’ within the meaning of Fifth Circuit precedent.” The district court accordingly denied Triad’s motion to compel on waiver grounds. Triad timely appealed. See 9 U.S.C. § 16(a)(1)(C). We now review the district court’s waiver finding de novo. In re Mirant Corp., 613 F.3d 584, 588 (5th Cir. 2010). II “The right to arbitrate a dispute, like all contract rights, is subject to waiver.” Nicholas v. KBR, Inc., 565 F.3d 904, 907 (5th Cir. 2009). A party can waive its contractual right to arbitration by “substantially invok[ing] the judicial process.” Walker v. J.C. Bradford & Co., 938 F.2d 575, 577 (5th Cir. 1991) (citation omitted). “To invoke the judicial process, a ‘party must, at the very least, engage in some sort of overt act in court that evinces a desire to resolve the arbitrable dispute through litigation rather than arbitration.” Mirant, 613 F.3d at 589 (quoting Subway Equip. Leasing Corp. v. Forte, 169 F.3d 324, 329 (5th Cir. 1999)).

4 Case: 24-60028 Document: 81-1 Page: 5 Date Filed: 09/06/2024

One such “overt act” is moving to dismiss under Rule 12(b)(6). Indeed, since Twombly, Iqbal, and the introduction of the “plausibility” standard, motions to dismiss for failure to state a claim have taken on a central, gatekeeping role in “weeding out meritless claims.” Fifth Third Bancorp v. Dudenhoeffer, 573 U.S. 409, 425 (2014). So, in some instances, a defendant can attempt to adjudicate the merits of a plaintiff’s claim under a Rule 12(b)(6) motion, asserting either that there is a fundamental flaw in the plaintiff’s legal theory, see, e.g., Nietzke v. Williams, 490 U.S. 319, 326–27 (1989), or that the defendant is entitled to dismissal based on an affirmative defense, see, e.g., Clark v. Amoco Prod.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Pumphrey v. Triad Life Sciences, Counsel Stack Legal Research, https://law.counselstack.com/opinion/pumphrey-v-triad-life-sciences-ca5-2024.